What Kinds of Breast Cancer Does Ibrance Treat? Breast cancer that is hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative and is advanced or has spread to other ...
Ibrance (palbociclib) is a prescription drug used to slow the progress of metastatic breast cancer. Foods to avoid while taking Ibrance include grapefruit and grapefruit products. Healthcare ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced positive top-line results from the Phase 3 PALOMA-2 trial for IBRANCE ® (palbociclib), an oral, first-in-class inhibitor of ...
Endocrine therapy, particularly when administered in combination with Verzenio (abemaciclib), is effective when compared with chemotherapy among patients with metastatic breast cancer who experienced ...
IBRANCE is an oral inhibitor of CDKs 4 and 6, 1 which are key regulators of the cell cycle that trigger cellular progression. 2,3 In the U.S., IBRANCE is a prescription medicine indicated for the ...
– Overall response rate of 42% and median progression-free survival of 11.1 months in heavily pre-treated patients (after 11 months median follow-up time and based on 48% of events) demonstrates the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results